A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 637-642

  Kim, Chang Gun ^a   Chung, Il Yup ^b   Lim, Yoongho ^a   Lee, Young Han ^a   Shin, Soon Young ^a  

^a Konkuk University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Catenin; Dvl 1; GSK 3 ; NANOG; Tcf Lef

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; SHORT HAIRPIN RNA; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR NANOG;

ARTICLE; BIOACCUMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BETA CATENIN; ENHANCER ELEMENTS, GENETIC; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 79960034683     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.044     Document Type: Article

References (25)

1. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
2. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
3. Hyslop L., Stojkovic M., Armstrong L., Walter T., Stojkovic P., Przyborski S., Herbert M., Murdoch A., Strachan T., Lako M. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 2005, 23:1035-1043.
4. Darr H., Mayshar Y., Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 2006, 133:1193-1201.
5. Xu R.H., Sampsell-Barron T.L., Gu F., Root S., Peck R.M., Pan G., Yu J., Antosiewicz-Bourget J., Tian S., Stewart R., Thomson J.A. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008, 3:196-206.
6. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., Robson P. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 2005, 280:24731-24737.
7. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., Nakatsuji N., Tada T. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 2005, 25:2475-2485.
8. Wei Z., Yang Y., Zhang P., Andrianakos R., Hasegawa K., Lyu J., Chen X., Bai G., Liu C., Pera M., Lu W. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells 2009, 27:2969-2978.
9. Lin T., Chao C., Saito S., Mazur S.J., Murphy M.E., Appella E., Xu Y. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 2005, 7:165-171.
10. Hao J., Li T.G., Qi X., Zhao D.F., Zhao G.Q. WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev. Biol. 2006, 290:81-91.
11. Ogawa K., Nishinakamura R., Iwamatsu Y., Shimosato D., Niwa H. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem. Biophys. Res. Commun. 2006, 343:159-166.
12. Singla D.K., Schneider D.J., LeWinter M.M., Sobel B.E. wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochem. Biophys. Res. Commun. 2006, 345:789-795.
13. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
14. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10:55-63.
15. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96:5522-5527.
16. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
17. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
18. Pereira L., Yi F., Merrill B.J. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol. Cell. Biol. 2006, 26:7479-7491.
19. Shin S.Y., Chin B.R., Lee Y.H., Kim J.H. Involvement of glycogen synthase kinase-3beta in hydrogen peroxide-induced suppression of Tcf/Lef-dependent transcriptional activity. Cell Signal. 2006, 18:601-607.
20. Travis A., Amsterdam A., Belanger C., Grosschedl R. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev. 1991, 5:880-894.
21. Sievers S., Fritzsch C., Grzegorczyk M., Kuhnen C., Muller O. Absolute beta-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells. Biomarkers 2006, 11:270-278.
22. Smith K.J., Johnson K.A., Bryan T.M., Hill D.E., Markowitz S., Willson J.K., Paraskeva C., Petersen G.M., Hamilton S.R., Vogelstein B., et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA 1993, 90:2846-2850.
23. Wagner R.T., Xu X., Yi F., Merrill B.J., Cooney A.J. Canonical Wnt/beta-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells 2010, 28:1794-1804.
24. Merrill B.J., Gat U., DasGupta R., Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 2001, 15:1688-1705.
25. Piestun D., Kochupurakkal B.S., Jacob-Hirsch J., Zeligson S., Koudritsky M., Domany E., Amariglio N., Rechavi G., Givol D. Nanog transforms NIH3T3 cells and targets cell-type restricted genes. Biochem. Biophys. Res. Commun. 2006, 343:279-285.